title: Major radiodiagnostic imaging in pregnancy and the risk of childhood malignancy: a population-based cohort study in Ontario.
abstract: BACKGROUND
  The association between fetal exposure to major radiodiagnostic testing in pregnancy-computed tomography (CT) and radionuclide imaging-and the risk of childhood cancer is not established.
  
  
  RESULTS
  We completed a population-based study of 1.8 million maternal-child pairs in the province of Ontario, from 1991 to 2008. We used Ontario's universal health care-linked administrative databases to identify all term obstetrical deliveries and newborn records, inpatient and outpatient major radiodiagnostic services, as well as all children with a malignancy after birth. There were 5,590 mothers exposed to major radiodiagnostic testing in pregnancy (3.0 per 1,000) and 1,829,927 mothers not exposed. The rate of radiodiagnostic testing increased from 1.1 to 6.3 per 1,000 pregnancies over the study period; about 73% of tests were CT scans. After a median duration of follow-up of 8.9 years, four childhood cancers arose in the exposed group (1.13 per 10,000 person-years) and 2,539 cancers in the unexposed group (1.56 per 10,000 person-years), a crude hazard ratio of 0.69 (95% confidence interval 0.26-1.82). After adjusting for maternal age, income quintile, urban status, and maternal cancer, as well as infant sex, chromosomal or congenital anomalies, and major radiodiagnostic test exposure after birth, the risk was essentially unchanged (hazard ratio 0.68, 95% confidence interval 0.25-1.80).
  
  
  CONCLUSIONS
  Although major radiodiagnostic testing is now performed in about 1 in 160 pregnancies in Ontario, the absolute annual risk of childhood malignancy following exposure in utero remains about 1 in 10,000. Since the upper confidence limit of the relative risk of malignancy may be as high as 1.8 times that of an unexposed pregnancy, we cannot exclude the possibility that fetal exposure to CT or radionuclide imaging is carcinogenic.
authors.affiliation: Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada. rayj@smh.toronto.on.ca
authors.forename: Joel G
authors.initials: JG
authors.lastname: Ray
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Schull
authors.forename: Marcelo L
authors.initials: ML
authors.lastname: Urquia
authors.forename: John J
authors.initials: JJ
authors.lastname: You
authors.forename: Astrid
authors.initials: A
authors.lastname: Guttmann
authors.forename: Marian J
authors.initials: MJ
authors.lastname: Vermeulen
mesh_terms: D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D016001:Confidence Intervals; D005260:Female; D006801:Humans; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced / Q000453:epidemiology* / Q000209:etiology; D009864:Ontario; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000453:epidemiology* / Q000209:etiology; D011877:Radionuclide Imaging / Q000009:adverse effects*; D012307:Risk Factors; D014057:Tomography, X-Ray Computed / Q000009:adverse effects*